Sign In
Get Clay Free →

Suggestions

    Chris Benko

    CEO at Koneksa Health

    Chris Benko is the CEO and co-founder of Koneksa Health, a company specializing in digital biomarkers for the pharmaceutical and biotechnology industries. He has over 25 years of experience in the pharmaceutical sector, particularly with Merck, where he held various executive roles including Vice President of Strategic Planning and Global Talent Management. Benko launched Koneksa while serving as an entrepreneur-in-residence with Merck’s corporate venture capital fund, eventually establishing it as an independent entity in January 2014.12

    Education

    • Bachelor's Degree from Bucknell University (1994 - 1998)
    • MBA from Duke University's Fuqua School of Business (2004 - 2006) .1

    Career Highlights

    • Koneksa Health: CEO since January 2014, leading the company in developing solutions for remotely collected clinical data to enhance drug development processes.
    • Merck: Held multiple positions from 1995 to 2015, culminating in roles that shaped global talent management and strategic planning.12

    Benko's leadership at Koneksa has been pivotal in advancing patient-centric approaches in clinical research, aiming to improve the efficiency and meaningfulness of clinical trials.2

    Highlights

    Feb 8 · founderlodge.com
    Koneksa raises $45000000 at Series C on 2022-02-08
    Nov 19 · pwc.com
    Chris Benko

    Related Questions

    What inspired Chris Benko to start Koneksa Health?
    How did Chris Benko's role at Merck prepare him for leading Koneksa?
    What are some of the key achievements under Chris Benko's leadership at Koneksa?
    How does Koneksa Health's approach to digital biomarkers differ from other companies?
    What challenges has Chris Benko faced in the pharmaceutical industry?
    Chris Benko
    Chris Benko, photo 1
    Chris Benko, photo 2
    Add to my network

    Location

    New York, New York, United States